{"version":"1.0","type":"rich","provider_name":"Acast","provider_url":"https://acast.com","height":250,"width":700,"html":"<iframe src=\"https://embed.acast.com/$/622b8f5080a3a00013890f23/640b72e83375ac00115c7b7b?\" frameBorder=\"0\" width=\"700\" height=\"250\"></iframe>","title":"The Growing Popularity of GLP-1 Drugs Like Ozempic and Wegovy","thumbnail_width":200,"thumbnail_height":200,"thumbnail_url":"https://open-images.acast.com/shows/622b8f5080a3a00013890f23/show-cover.png?height=200","description":"<p>Prescription drugs meant to treat chronic conditions like type 2 diabetes and obesity have caught the public’s attention for one of their side effects: weight loss. On today’s episode of Gist Healthcare Daily, we hear the first part of a two-part conversation about GLP-1 drugs, from an overview of how they work to how they are being incorporated into patient care. Veronica Johnson, MD of Northwestern University joins the podcast.&nbsp;</p><p><br></p><p><br></p>","author_name":"Gist Healthcare Daily"}